$547 Million is the total value of Boxer Capital, LLC's 26 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 83.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MDCO | Sell | MEDICINES COMPANY | $20,505,000 | -38.5% | 750,000 | -16.7% | 3.75% | -50.6% |
| ONTXW | Sell | ONCONOVA THERAPEUTICS INC*w exp 07/07/202 | $133,000 | -74.8% | 241,644 | -21.7% | 0.02% | -80.0% |
| ONTX | Exit | ONCONOVA THERAPEUTICS INC | $0 | – | -241,644 | -100.0% | -0.02% | – |
| NBRV | Exit | NABRIVA THERAPEUTICS AGsponsored adr | $0 | – | -86,710 | -100.0% | -0.16% | – |
| EIGR | Exit | EIGER BIOPHARMACEUTICALS INC | $0 | – | -138,331 | -100.0% | -0.35% | – |
| VXX | Exit | BARCLAYS BK PLCipath s&p 500 vix | $0 | – | -50,000 | -100.0% | -0.45% | – |
| AXGT | Exit | AXOVANT SCIENCES LTD | $0 | – | -500,000 | -100.0% | -0.78% | – |
| SBBP | Exit | STRONGBRIDGE BIOPHARMA PLC | $0 | – | -856,900 | -100.0% | -1.35% | – |
| RETA | Exit | REATA PHARMACEUTICALS INCcl a | $0 | – | -200,000 | -100.0% | -1.42% | – |
| ZGNX | Exit | ZOGENIX INC | $0 | – | -200,000 | -100.0% | -1.60% | – |
| PBYI | Exit | PUMA BIOTECHNOLOGY INC | $0 | – | -100,000 | -100.0% | -2.73% | – |
| CLVS | Exit | CLOVIS ONCOLOGY INC | $0 | – | -500,000 | -100.0% | -9.38% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 32 | Q3 2023 | 55.2% |
| BEIGENE LTD | 31 | Q3 2023 | 15.6% |
| KURA ONCOLOGY INC. | 24 | Q3 2021 | 4.7% |
| ROCKET PHARMACEUTICALS INC | 23 | Q3 2023 | 5.4% |
| DBV TECHNOLOGIES S A | 23 | Q3 2023 | 3.9% |
| MEI PHARMA INC | 21 | Q2 2023 | 1.4% |
| SYNDAX PHARMACEUTICALS INC | 20 | Q3 2021 | 3.1% |
| GOSSAMER BIO INC | 19 | Q3 2023 | 4.7% |
| ODONATE THERAPEUTICS INC | 18 | Q1 2022 | 12.5% |
| ESPERION THERAPEUTICS INC NE | 18 | Q2 2021 | 11.0% |
View Boxer Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| IDEAYA Biosciences, Inc. | February 14, 2023 | 2,202,812 | 4.6% |
| Milestone Pharmaceuticals Inc. | February 14, 2023 | 698,861 | 2.0% |
| SpringWorks Therapeutics, Inc. | September 19, 2022 | 3,421,541 | 5.7% |
| Atreca, Inc. | February 14, 2022 | 2,202,333 | 7.2% |
| Biomea Fusion, Inc. | February 14, 2022 | 1,188,405 | 4.1% |
| Cabaletta Bio, Inc. | February 14, 2022 | 540,000 | 1.9% |
| CymaBay Therapeutics, Inc. | February 14, 2022 | ? | ? |
| DBV Technologies S.A. | February 14, 2022 | 1,067,299 | 1.9% |
| Elevation Oncology, Inc. | February 14, 2022 | 872,780 | 3.8% |
| F-star Therapeutics, Inc. | February 14, 2022 | ? | ? |
View Boxer Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 4 | 2024-05-14 |
| SC 13D/A | 2024-05-14 |
| SC 13G | 2024-04-22 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-12 |
| 4 | 2024-02-08 |
| SC 13D/A | 2024-02-08 |
| 4 | 2024-01-25 |
View Boxer Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.